详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Leukemia-associated antigens are immunogenic and have prognostic value in acute myeloid leukemia

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

单位： [1]Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany [2]Huazhong Univ Sci & Technol, Dept Oncol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China

出处：

DOI：

ISSN：

关键词： acute myeloid leukemia immunotherapy leukemia-associated antigens RHAMM vaccination

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2010]版：

大类 | 4 区医学

小类 | 4 区免疫学

最新[2025]版：

大类 | 4 区医学

小类 | 4 区免疫学

JCR分区：

出版当年[2009]版：

Q4 IMMUNOLOGY

最新[2023]版：

Q3 IMMUNOLOGY

影响因子： 2.7 最新[2023版] 2.9 最新五年平均 0 出版当年[2009版] 0 出版当年五年平均 0 出版前一年[2008版] 0.542 出版后一年[2010版]

第一作者：

第一作者单位： [1]Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany [2]Huazhong Univ Sci & Technol, Dept Oncol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China

通讯作者：

通讯机构： [1]Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany [*1]Univ Ulm, Dept Internal Med 3, Albert Einstein Allee 23, D-89081 Ulm, Germany

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]IKAROS6 is associated with BCR-ABL1 and myeloid-associated antigens but indicates poor prognosis independently in Chinese adult B-cell acute lymphoblastic leukemia [2]IKAROS6 is associated with BCR-ABL1 and myeloid-associated antigens but indicates poor prognosis independently in Chinese adult B-cell acute lymphoblastic leukemia [3]Ikaros6 is associated with BCR-ABL1 and myeloid-associated antigens but indicates poor prognosis independently in Chinese adult B-cell acute lymphoblastic leukemia. [4]Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy [5]急性髓系白血病免疫治疗最新研究进展 [6]Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development [7]Osteopontin is required for the maintenance of leukemia stem cells in acute myeloid leukemia [8]Case report: A rare case of acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia [9]XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway [10]Small molecule activation of NOTCH signaling inhibits acute myeloid leukemia